Marijuana and DOT Testing: What Federal Rules Still Require

As marijuana legalization has spread across the country, confusion about DOT drug testing has grown with it. The short answer is straightforward: state law does not change federal DOT obligations. A positive result is a violation — regardless of where the employee lives, where they used it, or whether a state considers it legal.

The Federal-State Conflict

Marijuana remains a Schedule I controlled substance under federal law. DOT drug testing is a federal program governed by federal law — specifically 49 CFR Part 40. The DOT has been explicit on this point in multiple guidance notices: state marijuana laws, medical marijuana programs, and recreational marijuana legalization have no effect on DOT testing requirements.

Virginia has legalized recreational marijuana. Maryland has legalized recreational marijuana. Washington, D.C. has a complex cannabis framework. None of these matter for DOT purposes. A CDL driver, airline mechanic, railroad worker, or transit employee in any of these jurisdictions is still subject to federal DOT drug testing requirements — and marijuana is still on the test panel.

What DOT Tests Detect

The DOT 5-panel test includes marijuana metabolites (THC-COOH) as one of the five tested substances. The laboratory tests for the presence of these metabolites in urine, which can reflect use that occurred days or weeks before the collection depending on the frequency and amount of use. The DOT test does not measure current impairment — it detects prior exposure to the substance.

The cutoff levels are set by SAMHSA: the initial screening cutoff for marijuana metabolites is 50 ng/mL, and the confirmation cutoff is 15 ng/mL. A specimen must exceed both cutoff levels to be reported as positive.

No Medical Exception

The MRO cannot verify a medical marijuana authorization as a legitimate medical explanation for a positive DOT result. There is no federally recognized prescription for marijuana. A positive DOT test for marijuana is reported as positive regardless of state-issued medical marijuana cards or physician recommendations.

CBD Products and DOT Testing

The rise of CBD (cannabidiol) products has created another area of confusion. The DOT has specifically addressed this: employees who use CBD products cannot rely on that use to explain a positive DOT drug test result.

CBD products are not consistently regulated for THC content. Some products labeled as "THC-free" have been found to contain detectable levels of THC. Because the DOT test detects THC metabolites — not the specific source of them — CBD product use does not provide a defense to a positive result. Employees who test positive cannot attribute the result to CBD use and expect the MRO to report it as negative.

Consequences of a Positive Result

A positive DOT drug test for marijuana — like a positive for any other substance on the panel — triggers immediate removal from safety-sensitive duty. The employee cannot return to safety-sensitive work until they have completed a SAP evaluation, any required treatment or education, and a negative return-to-duty drug test followed by a SAP-prescribed follow-up testing plan.

The violation is also reported to the FMCSA Drug and Alcohol Clearinghouse for commercial drivers, where it is visible to current and prospective DOT-regulated employers for five years. This has significant implications for employment in the commercial transportation industry.

What Employers Should Communicate

Given the pace of state-level legalization, many safety-sensitive employees may genuinely not understand that marijuana use — even legal, recreational use in a legal state on a weekend — can still result in a DOT violation and loss of their safety-sensitive position. Clear, documented communication about this in the employer's written policy is essential.

The policy should state explicitly that regardless of state law, employees subject to DOT testing are prohibited from marijuana use and will be tested for marijuana as part of the DOT 5-panel. This is not a matter of employer preference — it is a federal requirement, and the employer's policy simply must reflect it.

Non-DOT Programs and Marijuana

Non-DOT employers have more flexibility. In states where marijuana is legal, employers may choose to remove marijuana from their non-DOT testing panel or to limit adverse action based on marijuana results depending on their state's employment laws. This is a legal and policy decision that varies by state and industry — and is entirely separate from the DOT testing obligations that apply to safety-sensitive employees.